Long-Acting Injection
Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
11
Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
8
A pooled analysis of injection site related adverse events in patients with schizophrenia treated with olanzapine long acting injection
5
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
10
Dose associated changes in safety and efficacy parameters observed in a 24 week maintenance trial of olanzapine long acting injection in patients with schizophrenia
10
Risperidone long acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
9
A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder
8
Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
9
Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection
9
Treatment and control of bovine hypodermosis with ivermectin long acting injection (IVOMEC® GOLD)
6
Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long acting injection: a case report
7
Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, I: analysis of cases
10
Olanzapine long acting injection: a review of first experiences of post injection delirium/sedation syndrome in routine clinical practice
8
Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, II: investigations of mechanism
10
Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
5
Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
5
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
7
Schizophrenia symptoms and functioning in patients receiving long term treatment with olanzapine long acting injection formulation: a pooled analysis
11
Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
10
Long acting olanzapine versus long acting risperidone for schizophrenia in Spain – a cost effectiveness comparison
12